A new prospective study published today in the Endocrine Society's Journal indicates that moderate caffeine consumption (200-300 mg/day) is associated with a lower risk of developing multiple cardiometabolic diseases by significant margins.
The study analyzed data from the UK Biobank, with over 500,000 participants, revealing that those who consumed moderate caffeine faced a 48% reduced risk of diseases such as stroke and diabetes.
Collection
[
|
...
]